Skip to main content
    D

    Doximity Inc (DOCS)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $31.13
    -1.64 (-5.00%)

    Market Cap: $5.95B

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Doximity Inc (DOCS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Doximity (DOCS) has a market cap of $5.95B and an enterprise value of $5.73B. Its share count is down 4.81% from a year earlier. Its trailing P/E of 29.6x is below its 5-year median of 39.4x.

    Total Valuation

    Enterprise value is 3.68% below the market cap, as cash exceeds debt.

    Market Cap$5.95B
    Enterprise Value$5.73B
    Latest price (Nov 17, 2026)$31.13

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count fell 2.13% in the quarter ended Sep 30, 2026 and shrank 2.06% a year over 2 years.

    Shares Outstanding178.67M
    Shares Change (YoY)-4.81%
    Shares Change (QoQ)-2.13%
    Share Count Growth (2Y CAGR)-2.06%

    Valuation Ratios

    Sales and book value multiples are 8.4x and 6.0x. Its year-end P/E ranged from 29.5x to 77.1x from 2021 to 2025.

    P/E Ratio29.6x
    Forward P/E22.6x
    P/S Ratio8.4x
    Forward P/S8.7x
    P/B Ratio6.0x
    P/TBV Ratio6.8x
    P/FCF Ratio18.7x
    P/OCF Ratio19.5x
    PEG Ratio5.1

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 23.8x EBITDA and 18.0x free cash flow.

    EV / Earnings41.0x
    EV / Sales8.7x
    EV / EBITDA23.8x
    EV / FCF18.0x

    Price Statistics

    The stock is down 37.26% over 52 weeks and trades 3.77% above its 50-day average.

    Beta (1Y)0.61
    52-Week Change-37.26%
    1-Month Change-1.02%
    3-Month Change+20.89%
    6-Month Change+61.63%
    5-Year Change-52.85%
    Total Return (1Y)-37.26%
    Total Return (3Y CAGR)+8.10%
    Total Return (5Y CAGR)-13.82%
    Return vs SPY (1Y)-45.91%
    Max Drawdown (1Y)-65.05%
    Max Drawdown (3Y)-78.34%
    Sharpe Ratio (1Y)-0.67
    Correlation with SPY (1Y)0.13
    50-Day Average$30.00
    200-Day Average$25.14
    52-Week Range$17.15 to $51.84
    RSI (14 Days)45.0
    Average Volume (20 Days)2.39M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.37x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.37x
    Quick Ratio6.37x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 15.05% over the last 12 months, against a 5-year average of 17.38%.

    Return on Equity (ROE)15.05%
    Return on Assets (ROA)12.80%
    ROE (5Y Average)17.38%
    ROA (5Y Average)14.86%
    ROIC (5Y Average)17.73%
    Asset Turnover0.56x
    Receivables Turnover3.85x

    Taxes

    Income tax took 31.38% of pretax income over the last 12 months.

    Income Tax (TTM)$63.89M
    Effective Tax Rate31.38%

    Scores

    DOCS has an Altman Z-Score of 22.31, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score22.31
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $661.58M over the last 12 months is up 6.48% from the 12 months before.

    Revenue$661.58M
    Revenue Growth (YoY)+6.48%
    Gross Profit$574.43M
    Operating Income$174.29M
    Pretax Income$203.61M
    Net Income$139.72M
    EBITDA$224.12M
    Reported EPS (TTM)$1.05

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 85.18% of the $1.09B in total assets.

    Cash and Equivalents$218.61M
    Total Debt$0
    Net Cash$218.61M
    Net Cash Per Share$1.22
    Working Capital$776.95M
    Shareholder Equity$928.48M
    Book Value Per Share$5.20
    Tangible Book Value$812.07M
    Tangible Book Per Share$4.54
    Total Assets$1.09B
    Total Liabilities$163.29M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $8.90M of capital spending, operating cash flow left $296.78M of free cash flow.

    Operating Cash Flow$305.69M
    Capital Expenditures$8.90M
    Free Cash Flow$296.78M
    FCF Per Share$2.33
    Depreciation and Amortization$27.80M
    Share Repurchases$433.24M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 26.34%, against a 5-year average of 34.13%.

    Gross Margin86.83%
    Operating Margin26.34%
    Pretax Margin30.78%
    Net Margin21.12%
    EBITDA Margin33.88%
    FCF Margin44.86%
    Gross Margin (5Y Average)88.86%
    Operating Margin (5Y Average)34.13%
    Net Margin (5Y Average)34.51%

    Growth

    Revenue grew 15.45% a year over 3 years, and EPS 25.41% a year.

    Revenue Growth (3Y CAGR)+15.45%
    Revenue Growth (5Y CAGR)+25.53%
    EPS Growth (3Y CAGR)+25.41%
    EPS Growth (5Y CAGR)+79.63%
    FCF Growth (3Y CAGR)+22.34%
    FCF Growth (5Y CAGR)+32.29%
    Operating Income Growth (3Y CAGR)+19.77%
    Book Value Per Share Growth (2Y CAGR)+4.30%
    Tangible Book Per Share Growth (2Y CAGR)+3.07%

    Revenue and profit by year

    Dividends and Yields

    DOCS does not pay a dividend. Its free cash flow yield is 5.34%.

    Earnings Yield3.38%
    FCF Yield5.34%
    Buyback Yield7.57%
    Shareholder Yield7.57%

    Peer Position

    Against 8 similar companies, DOCS has the 5th highest P/E.

    P/E Ratio29.6x vs 30.5x median
    P/S Ratio8.4x vs 2.0x median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.48% vs +17.02% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.87% and EPS growth at 3.76% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.87%
    EPS Growth Forecast (2Y CAGR)+3.76%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DOCS

    What is DOCS's market cap?

    Doximity has a market cap of $5.95B. Its enterprise value, which adds debt and subtracts cash, is $5.73B.

    What is DOCS's P/E ratio?

    Doximity has a trailing P/E ratio of 29.6x and a forward P/E of 22.6x.

    How many shares of DOCS are outstanding?

    Doximity has 178.67M shares outstanding. The count is down 4.81% from a year earlier.

    Does DOCS pay a dividend?

    No. Doximity does not pay a dividend.

    How much debt does DOCS have?

    Doximity has $0 of total debt and $218.61M of cash and equivalents, a net cash position of $218.61M.